Problems and prevention of viral hepatitis in Thailand

Y Poovorawan1, V Chongsrisawat, P Tangkijvanich

  • 1Department of Paediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Insights

Viral hepatitis remains a significant public health issue in Thailand. This review covers hepatitis A, B, C, D, E, G, TT, and SEN viruses, focusing on epidemiology, control, and prevention strategies.

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Viral hepatitis poses a major public health challenge in Thailand, leading to chronic liver diseases like cirrhosis and hepatocellular carcinoma (HCC).
  • Hepatitis A outbreaks persist despite declining rates, while Hepatitis D prevalence has decreased among intravenous drug users.
  • Hepatitis E is an uncommon cause of acute hepatitis, and new viruses (G, TT, SEN) require further study for their role in liver disease.

Purpose of the Study:

  • To review the current epidemiology of viral hepatitis in Thailand.
  • To discuss molecular biology and control strategies for viral hepatitis.
  • To highlight recent developments and research findings on hepatitis virus infections.

Main Methods:

  • Review of current epidemiological data on viral hepatitis in Thailand.
  • Analysis of molecular biology and pathogenesis of hepatitis viruses.
  • Assessment of prevention and control strategies, including vaccination and public health interventions.

Main Results:

  • Hepatitis B and C are leading causes of chronic liver disease and HCC.
  • Hepatitis A outbreaks continue, while Hepatitis D prevalence has declined in specific populations.
  • Effective vaccines exist for Hepatitis A and B, but not yet for Hepatitis C.

Conclusions:

  • Viral hepatitis necessitates ongoing public health efforts in Thailand.
  • Vaccination is key for Hepatitis A and B prevention.
  • Further research is needed to understand and control emerging hepatitis viruses and Hepatitis C.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...